or Try an Advanced Search...

    Immune Disorders Stocks List

    Symbol Grade Name % Change
    PLX B Protalix BioTherapeutics, Inc. 1.81
    VCNX C Vaccinex, Inc. 0.56
    BNTX D BioNTech SE 4.53
    NRIX D Nurix Therapeutics, Inc. -1.43
    BAX D Baxter International Inc. 0.67
    CUE D Cue Biopharma, Inc. -0.97
    CGEN F Compugen Ltd. -2.76
    STRO F Sutro Biopharma, Inc. -0.79
    TRIB F Trinity Biotech plc -6.15
    BIIB F Biogen Idec Inc. -0.07
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies
    Related Stock Lists: Autoimmune Disorders Biopharmaceutical Biotechnology Cancer Disease Life Sciences Medication Pharmacy

    Related ETFs - A few ETFs which own one or more of the above listed Immune Disorders stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 6.24
    BIS C ProShares UltraShort Nasdaq Biotechnology 6.12
    FBT C First Trust Amex Biotech Index Fund 5.85
    TPMN A The Timothy Plan Timothy Plan Market Neutral ETF 5.66
    PBE C PowerShares Dynamic Biotech & Genome 4.21
    View all Immune Disorders ETFs...
    Compare ETFs
    Compare BBH to BIS Compare BBH to TPMN Compare FBT to PBE

        Immune Disorders Stocks Recent News

        Date Stock Title
        Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
        Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
        Nov 21 BAX New Strong Sell Stocks for November 21st
        Nov 20 NRIX Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 BNTX BioNTech upgraded to Outperform from In Line at Evercore ISI
        Nov 20 BNTX Moderna initiated with a Hold at Berenberg
        Nov 20 BNTX BioNTech initiated with a Buy at Berenberg
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 BNTX Is BioNTech SE (BNTX) the Best German Stock to Buy Now?
        Nov 19 BAX Baxter to Present at 7th Annual Evercore HealthCONx Conference
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 BNTX BioNTech started at buy, Moderna at hold by Berenberg
        Nov 19 BNTX BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It.
        Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
        Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
        Nov 18 STRO Sutro Biopharma (STRO) Upgraded to Buy: Here's What You Should Know
        Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
        Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
        Nov 18 BIIB Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Major Medical Instruments & Supplies
        Related Stock Lists: Autoimmune Disorders Biotechnology Medicine Cancer Immunology Antibodies Biopharmaceutical Life Sciences Autoimmunity Biology Clinical Medicine Infectious Diseases Lymphoma Monoclonal Antibodies Multiple Sclerosis Antibody Biomarkers Degenerative Disease Drug Discovery Fusion Protein
        Immune Disorders

        Immune disorders are conditions that occur when the body's immune system is not functioning properly. These disorders can cause the body to be more susceptible to infections, or can cause the body to attack its own cells and tissues. Examples of immune disorders include allergies, asthma, autoimmune diseases, and immunodeficiency disorders.

        Browse All Tags